Intralesional Hyaluronic Acid and Verapamil Injection in Peyronie's Disease
Status:
Not yet recruiting
Trial end date:
2024-05-20
Target enrollment:
Participant gender:
Summary
The aim of the present study is to investigate whether intralesional injections of Hyaluronic
acid in the acute phase could reduce the progression of Peyronie's disease thanks to its
interference with inflammatory and pro-fibrotic processes.
Therefore, a prospective, longitudinal, double-blinded, randomized clinical study, has been
designed to evaluate and compare the efficacy and safety of intralesional HA as compared with
the use of verapamil injection in patients affected by Peyronie's disease.